Cite
Mirdamadi A, Dashtkar S, Kaji M, et al. Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial. ARYA Atheroscler. 2014;10(6):292-7
Mirdamadi, A., Dashtkar, S., Kaji, M., Pazhang, F., Haghpanah, B., & Gharipour, M. (2014). Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial. ARYA atherosclerosis, 10(6), 292-7.
Mirdamadi, Ahmad, et al. "Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial." ARYA atherosclerosis vol. 10,6 (2014): 292-7.
Mirdamadi A, Dashtkar S, Kaji M, Pazhang F, Haghpanah B, Gharipour M. Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial. ARYA Atheroscler. 2014 Nov;10(6):292-7. PMID: 25815018; PMCID: PMC4354081.
Copy
Download .nbib